Welcome at the Associate Professorship of Exercise Biology!
Slide 1 of 5
Our strategy: Many athletic performances are critically dependent on metabolic function, and physical training is effective in preventing and treating metabolic diseases such as diabetes mellitus and obesity. The Exercise Biology group at the TU Munich therefore aims to investigate topics related to sports and metabolism often with disease relevance. We often use state-of-the-art methods of metabolic research such as arteriovenous metabolomics analyses and metabolic flux analyses as well as methods of molecular sports physiology. Our main goal with this strategy is to mechanistically answer important unanswered questions in the field. We want to discover new phenomena that help athletes optimize their performance, help patients recover, and ultimately help all people who want to stay fit and healthy for a long time.
The group of Jonathan Long, Stanford, has identified several amino acid-carboxylic acid conjugates that are modulated by exercise and that have an effect on metabolism. Recent examples are lactoyl-phenylalanine (Li, He et al. 2022) and N-acetyltaurine (Wei, Lyu et al. 2024). We propose to use the…
[read more]
2024 was an eventful and successful year at the Exercise Biology. A significant milestone is and was the DFG funding application for the HyperMet research group, for which we received approval from the DFG in September 2024. It will be a project that will accompany us for the next four to eight…
[read more]
We are happy to announce our new paper which results from our collaboration with the Institute of Fluid Mechanics and Aerodynamics (Universität der Bundeswehr) and the Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine (LMU Hospital). In this paper, we can show the…
[read more]
Skeletal muscle contributes 20-50% to body mass. In some cases, skeletal muscle is lost at a high rate (ICU-acquired muscle weakness, cancer cachexia) and in others at a low rate (sarcopenia). The aim of this symposium is to introduce different forms of atrophy and to discuss consequences and…
[read more]
Animal studies suggest that ageing can be treated like a disease. But what about human longevity trials? Should future physicians treat ageing, a natural process? Is it the ultimate disease prevention? Is it ethical? This symposium aims to start a debate on this topic. The keynote speaker is Prof.…
[read more]